Researchers examined how to choose the right participants for clinical trials focused on pediatric developmental and epileptic encephalopathies, which are severe forms of epilepsy that affect brain development.
Researchers studied how certain genetic variations in the ADORA2A gene might affect how children with epilepsy respond to two medications: valproic acid and oxcarbazepine.
Researchers studied the use of a medication called cenobamate in children with focal epilepsies and developmental epileptic encephalopathies.
Researchers studied the effects of rapid genomic testing on children who were seriously ill and had severe epilepsy.
Researchers studied how neurocognitive issues, behavior problems, and the treatment process affect stress levels in parents of children with epilepsy.
Researchers studied how personality changes in people with temporal lobe epilepsy (TLE) might be linked to inflammation and brain imaging.
Researchers conducted a study to evaluate the effectiveness of a medication called fremanezumab in treating patients who experience migraines and also have major depressive disorder.
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Researchers conducted a systematic review and meta-analysis to explore how smartphone-based tools can help diagnose epileptic seizures.